PERSPECTIVES: Stroke survivors' views on the design of an early‐phase cell therapy trial for patients with chronic ischaemic stroke-Reference-Cited by-同舟云学术

PERSPECTIVES: Stroke survivors' views on the design of an early‐phase cell therapy trial for patients with chronic ischaemic stroke

Published:2019-07-23 Issue:5 Volume:22 Page:1069-1077
ISSN:1369-6513
Container-title:Health Expectations
language:en
Short-container-title:Health Expect

Author:

Nagpal Anjali¹^ORCID,Hillier Susan²,Milton Austin G.³,Hamilton‐Bruce Monica A.¹³,Koblar Simon A.¹³

Affiliation:

1. Stroke Research Programme, Adelaide Medical School, The University of Adelaide South Australian Health & Medical Research Institute (SAHMRI) Adelaide SA Australia

2. Sansom Institute for Health Research University of South Australia Adelaide SA Australia

3. Stroke Research Programme, Departments of Neurology and Medicine The Queen Elizabeth Hospital, & Royal Adelaide Hospital, Central Adelaide Local Health Network (CALHN) Adelaide SA Australia

Funder

Stroke SA

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hex.12932

Reference34 articles.

1. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010

2. Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis

3. Novel Approaches to Neuroprotection Trials in Acute Ischemic Stroke